Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device.
Eur J Med Res
; 28(1): 291, 2023 Aug 18.
Article
in En
| MEDLINE
| ID: mdl-37596670
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Respiratory Insufficiency
/
Body Fluids
/
Continuous Renal Replacement Therapy
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2023
Type:
Article